Theresa A. Ward
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Theresa A. Ward has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Ronald D. Miller
University of California San Francisco, San Francisco, CA, USA
2 shared publications - Andrea J. Barczak
UCSF Genomics CoLab, Department of Medicine, University of California San Francisco, San Francisco, CA 94143, USA
1 shared publication - Assel Biyasheva
Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA
1 shared publication - Charles E. McCulloch
Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA
1 shared publication - Chris Eisley
Sandler Asthma Basic Research (SABRE) Center Functional Genomics Core Facility, University of California San Francisco, San Francisco, CA, USA
1 shared publication - David J. Erle
University of California San Francisco, San Francisco, USA
1 shared publication
Latest Publications
- Open Access
- 17 January 2014
- Published by Springer Nature in Genome Medicine
- Vol. 6 (1) , 1
Asthmatics with exacerbation during acute respiratory illness exhibit unique transcriptional signatures within the nasal mucosa
Background: Acute respiratory illness is the leading cause of asthma exacerbations yet the mechanisms underlying this association remain unclear. To address the deficiencies in our understanding of the molecular events characterizing acute respiratory illness-induced asthma exacerbations, we undertook a transcriptional profiling study of the nasal mucosa over the course of acute respiratory illness amongst individuals with a history of asthma, allergic rhinitis and no underlying respiratory disease. Methods: Transcriptional profiling experiments were performed using the Agilent Whole Human Genome 4X44K array platform. Time point-based microarray and principal component analyses were conducted to identify and distinguish acute respiratory illness-associated transcriptional profiles over the course of our study. Gene enrichment analysis was conducted to identify biological processes over-represented within each acute respiratory illness-associated profile, and gene expression was subsequently confirmed by quantitative polymerase chain reaction. Results: We found that acute respiratory illness is characterized by dynamic, time-specific transcriptional profiles whose magnitudes of expression are influenced by underlying respiratory disease and the mucosal repair signature evoked during acute respiratory illness. Most strikingly, we report that people with asthma who experience acute respiratory illness-induced exacerbations are characterized by a reduced but prolonged inflammatory immune response, inadequate activation of mucosal repair, and the expression of a newly described exacerbation-specific transcriptional signature. Conclusion: Findings from our study represent a significant contribution towards clarifying the complex molecular interactions that typify acute respiratory illness-induced asthma exacerbations.
- 17 January 2014
- Published by Springer Nature in Genome Medicine
- Vol. 6 (1) , 1
Open AccessAsthmatics with exacerbation during acute respiratory illness exhibit unique transcriptional signatures within the nasal mucosa
Background: Acute respiratory illness is the leading cause of asthma exacerbations yet the mechanisms underlying this association remain unclear. To address the deficiencies in our understanding of the molecular events characterizing acute respiratory illness-induced asthma exacerbations, we undertook a transcriptional profiling study of the nasal mucosa over the course of acute respiratory illness amongst individuals with a history of asthma, allergic rhinitis and no underlying respiratory disease. Methods: Transcriptional profiling experiments were performed using the Agilent Whole Human Genome 4X44K array platform. Time point-based microarray and principal component analyses were conducted to identify and distinguish acute respiratory illness-associated transcriptional profiles over the course of our study. Gene enrichment analysis was conducted to identify biological processes over-represented within each acute respiratory illness-associated profile, and gene expression was subsequently confirmed by quantitative polymerase chain reaction. Results: We found that acute respiratory illness is characterized by dynamic, time-specific transcriptional profiles whose magnitudes of expression are influenced by underlying respiratory disease and the mucosal repair signature evoked during acute respiratory illness. Most strikingly, we report that people with asthma who experience acute respiratory illness-induced exacerbations are characterized by a reduced but prolonged inflammatory immune response, inadequate activation of mucosal repair, and the expression of a newly described exacerbation-specific transcriptional signature. Conclusion: Findings from our study represent a significant contribution towards clarifying the complex molecular interactions that typify acute respiratory illness-induced asthma exacerbations.
- 1 August 2012
- Published by Springer Nature in Journal of Anesthesia
- Vol. 26 (6) , 845-850
Does a digital regional nerve block improve the accuracy of noninvasive hemoglobin monitoring?
- 1 August 2012
- Published by Springer Nature in Journal of Anesthesia
- Vol. 26 (6) , 845-850
Does a digital regional nerve block improve the accuracy of noninvasive hemoglobin monitoring?
- 9 March 2011
- Published by Springer Nature in Journal of Anesthesia
- Vol. 25 (3) , 438-441
Possible augmentation of neuromuscular blockade by propofol during recovery from rocuronium
Propofol is a widely used drug in anesthesia practice, and its pharmacological characteristics are well known. However, propofol is not known for neuromuscular effects. As part of clinical neuromuscular monitoring, the neuromuscular responses to train-of-four (TOF) stimulation were monitored and recorded. We observed, in two cases of balanced anesthesia maintained by desflurane and fentanyl, that administration of a small dose of propofol during almost complete recovery from rocuronium in two patients resulted in marked decreases of both T1 (first twitch response of the TOF) and the TOF ratio. This neuromuscular block dissipated in both patients without any subsequent neuromuscular effects. These two observations provide visual confirmation of the possible impact of propofol on recovery from a rocuronium neuromuscular blockade.
- 9 March 2011
- Published by Springer Nature in Journal of Anesthesia
- Vol. 25 (3) , 438-441
Possible augmentation of neuromuscular blockade by propofol during recovery from rocuronium
Propofol is a widely used drug in anesthesia practice, and its pharmacological characteristics are well known. However, propofol is not known for neuromuscular effects. As part of clinical neuromuscular monitoring, the neuromuscular responses to train-of-four (TOF) stimulation were monitored and recorded. We observed, in two cases of balanced anesthesia maintained by desflurane and fentanyl, that administration of a small dose of propofol during almost complete recovery from rocuronium in two patients resulted in marked decreases of both T1 (first twitch response of the TOF) and the TOF ratio. This neuromuscular block dissipated in both patients without any subsequent neuromuscular effects. These two observations provide visual confirmation of the possible impact of propofol on recovery from a rocuronium neuromuscular blockade.